|
|
|
|
|
||||||||||||
|
|
|
|
|
|
|
|
價值評估 |
盈利(現時/預測)
-1.24/4.86
|
企業價值
24.42B
|
資產負債 |
每股賬面淨值
-3.04
|
現金流量 |
現金流量率
0.44
|
損益表 |
收益
8.76B
|
每股收益
23.29
|
同行比較
|
||||||||||||||||||||||||||||||||||||||||||||||||
|
報價延遲最少15分鐘:2024/05/20 14:15 EDT
同行比較之報價最少15分鐘延遲
業務概覽
|
|||
Bausch Health Companies Inc is a global specialty pharmaceutical, consumer health, and medical device company with a focus on branded products for the gastroenterology, hepatology, neurology and dermatology markets. The company reports revenue in five segments: Salix; International; Solta Medical; Diversified Products and Bausch + Lomb. It generates maximum revenue from the Bausch + Lomb segment. |